New evidence reveals tamoxifen reduces breast cancer rates by nearly a third for 20 years

The preventive effect of breast cancer drug ‘tamoxifen’ remains virtually constant for at least 20 years — with rates reduced by around 30 percent — new analysis published in The Lancet Oncology reveals. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *